A cDNA microarray and RT-PCR study of 20 oestrogen receptor-negative breast cancers identified RAI3 as one of the genes indicating poor patient survival (RAI3 was upregulated in the group of 10 patients who had died of breast cancer within 5 years after surgery [9]). This evidence concerns the gene GPRC5A and breast carcinoma.